Thursday, October 15, 2026

Is The Market Turning The Page?

CoreWeave’s debt and equity price action is framed as a wake-up call for investors amid a broader market discussion.

CRWV $34B

WHAT ARE WE DOING? “Contrarians At The Gate” Oct 15 51 clicks

Oct 15 ASML $631B

ASML Is Building a Hybrid Bonding Tool!

SemiAnalysis 11 clicks

Oct 15 APP $88B

AppLovin Deep Dive

Speedwell Research 24 clicks

From X

@AsifSuria Sep 30

Asif Suria on X

"Too busy counting his cash" 😀 $WBD He started even before the deal closed: https://t.co/NLDnCJldgP https://t.co/1SidBA0O6d

@aleabitoreddit Sep 30

Serenity on X

$GOOGL Gemini 4 Argon benchmarks got released. Against GPT-6 Astra + Anthropic Fable 5.1 / Opus 5.5. Still coughing nonstop, so will comment on $MU / $JBL earnings later. I've always thought Google's internal models were stellar, but anecdotally, they seem to get hard nerfed shortly after public release... Maybe because of compute constraints? But yeah, looks like Google is back.

@pitdesi Sep 30

Sheel Mohnot on X

These benchmarks are great, but I'm waiting to see how it does in the bridge benchmark :) also - probably should be long $GOOG https://t.co/5hdtMmiq4H https://t.co/4B1R4VX3J5

@negligible_cap Sep 30

Negligible Capital on X

Gemini 4 - "Across most benchmarks, Gemini 4 Argon beats OpenAI’s and Anthropic’s top models by a wide margin, and when it doesn’t, it is generally within striking distance of its competition." - New Stack $GOOG ripping. So back https://t.co/3mF0pFC7WN https://t.co/hybzgxCRRC

@ActAccordingly Sep 30

PAA Research on X

Following the action in $FICO, it seems this post from @pulte has drawn increased investor attention to $STC $FAF $ORI $FNF and their title insurance pricing policies. We have had a short call on $STC and $FAF for some time. There's no doubt there are several technology options that could lower title insurance costs (AI) if not eliminate the need for it altogether (blockchain). You already have many brokers offering bundled solutions for title, mortgage, and advisory. Lots of pressure on these busineses.

@aleabitoreddit Sep 30

Serenity on X

@DavidJang0620 I actually thought $JBL earnings were great. But usually if you disagree with how markets reacted, that just means there's a buying opportunity.

@irbezek Sep 30

Ian Bezek on X

@NthObject89773 @pradeeepk Given $APP's sketchy history of using data, rather ironic that they would complain about a little turnaround of their tactics.

@finphysnerd Sep 30

Myles on X

Corporates (spreads are tight, if this gets rly bad spreads should blow out). Long breadth, consumer exposure and small caps through stuff like $IWM, $RSP, $XSHQ, $RSPD. Short the narrow winners like $QQQ, $SMH, $AAPL, $CRWD, $ILMN, $NBIS. Also shorting long crowded bio longs

ASML 3Q’26: 2030 Arrived Four Years Early

ASML reported €11.7 billion in 3Q 2026 sales, up 55%, and raised full-year guidance to €44–45 billion as AI-driven semiconductor demand…

ASML $631B

MBI Deep Dives Oct 15 11 clicks

Berkshire B: Holding, Developing Headwinds Have Yet To Reflect In Stock Price, In My View

Berkshire Hathaway trades at 1.46 times book as reinsurance pricing pressure, softer P&C, concentrated equities and cash weigh on its…

BRK.A $1.1T

Pearl Gray Equity and Research Oct 15 3 clicks

[scuttleslops] MRVL, APP, AMZN, Chips

Marvell is positioning networking, optical connectivity and server-management chips as AI data centers link GPUs, custom accelerators and…

MRVL $208B

scuttleblurb Oct 15 12 clicks

Constellation: Stars Aligning?

Constellation Brands trades near $127 at roughly 11x next-twelve-month EV/EBIT, with recent business results offsetting concerns over…

STZ $22B

TSOH Investment Research Oct 15 27 clicks

Why Broadcom Is My Largest Stock Holding Today

AVGO $1.6T

Fundamental Options Oct 15 2 clicks

October 2026 Random Ramblings

October 2026 market commentary covers SOLS’s cancelled merger, a hypothetical Starbucks-Chipotle deal, Russell 2000 weakness and AI…

SBUX $109BCMG $39B

Yet Another Value Podcast Oct 14 86 clicks

An Interview with Nvidia’s Ian Buck on Why GPUs Keep Winning

Nvidia’s Ian Buck says CUDA’s software ecosystem, GPU flexibility and annual Vera Rubin upgrades lower token costs as agentic AI pushes…

NVDA $5.2T

Key Context by Tae Kim Oct 14 4 clicks

Everyone wants to defend CoreWeave but who really knows

CoreWeave faces fresh skepticism as another AI trade selloff collides with bullish defenses of the company.

CRWV $34B

The Technology Letter Oct 14 6 clicks

A Conversation With Ari Emanuel About Entertainment and AI

Ari Emanuel discusses AI’s impact on Hollywood, live events, social networks and the future of advertising.

TKO $33B

Stratechery by Ben Thompson – On the business, strategy, and impact of technology. Oct 14 7 clicks

RTX Q3 Preview: Two Growth Engines Make This Aerospace And Defense Leader A 'Buy'

RTX’s $289 billion backlog, including $119 billion in defense, supports growth from defense contracts and commercial aerospace aftermarket…

RTX $247B

Blake Winiecki Oct 14 4 clicks

Coherent | Management Call

COHR $52B

P Equity Research Oct 14 18 clicks

The Tesla Story Is Falling Apart, And A Flying Roadster Won't Save It

Tesla’s Q2 revenue rose 26%, but operating margin fell to 1.4% and free cash flow was negative $1.1 billion as valuation reached 215x…

TSLA $1.4T

Julia Ostian Oct 14 5 clicks

My 2028 numbers

ASML’s €11.7 billion quarter benefited from €3.3 billion in installed-base sales and operating leverage, while the MATCH Act threatens…

ASML $631B

Best Anchor Stocks Oct 14 24 clicks

Visa: Unpacking The 7 Powers And Forward Valuation Ahead Of Q4 Earnings

Visa’s network economics support long-term compounding, but a 1.7–1.8 forward PEG and risks to high-margin payment revenues limit near-term…

V $750B

C Jessen Oct 14 36 clicks

Deep Dive: Applied Materials ($AMAT)

Applied Materials leads wafer-fab deposition and ranks third in etch, positioning it for tougher 3D chip manufacturing as investors weigh a…

AMAT $359B

Rebound Capital Oct 14 29 clicks

First Tracks Biotherapeutics: Teva Validated The Pathway, ANB033 May Own The Receptor

First Tracks Biotherapeutics’ ANB033 posted stronger Phase 1b celiac efficacy than Teva’s IL-15 inhibitor, with $168 million funding…

TEVA $48B

Equity Eagle Oct 14 8 clicks

Research Roundup Vol. LVI

Howmet Aerospace is framed as a beneficiary of turbine and aircraft-engine demand, while J.B.

HWM $88BJBHT $22B

Monte Independent Investment Research Oct 14 14 clicks

Lennar: The Misstep Is Temporary, the Operating Machine Is Not

Lennar cut build times to 116 days and adopted an asset-light land model, while gross margin fell to 15.8% from 27.5% as land costs rose.

LEN $17B

Latticework by MOI Global Oct 14 14 clicks

Lennar, Part One: The Story

Lennar grew from a Miami builder into one of America’s two largest homebuilders, controlling land largely through options and land banks…

LEN $17B

Latticework by MOI Global Oct 14 14 clicks

Lennar, Part Two: The Deep Dive

Lennar’s second audio program examines the homebuilder’s business for professional investors and housing analysts.

LEN $17B

Latticework by MOI Global Oct 14 12 clicks

Thursday, October 15, 2026

Asif Suria on X

Serenity on X

Sheel Mohnot on X

Negligible Capital on X

PAA Research on X

Serenity on X

Ian Bezek on X

Myles on X

Investor Letters

Publications we follow

Newsletters 107

YouTube 4

Blogs 17

Seeking Alpha 52 of 235

X accounts we follow

Investor letters we follow

Sectors